Neuroprotective Effects of Dehydroepiandrosterone and Hericium erinaceus in Scopolamine-induced Alzheimer's Diseases-like Symptoms in Male Rats
- PMID: 38990419
- DOI: 10.1007/s12013-024-01400-y
Neuroprotective Effects of Dehydroepiandrosterone and Hericium erinaceus in Scopolamine-induced Alzheimer's Diseases-like Symptoms in Male Rats
Abstract
Background: The neuroprotective effects of Dehydroepiandrosterone (DHEA) and Hericium erinaceus (H. erinaceus) mushroom extract against scopolamine-induced Alzheimer's disease-like symptoms in male Wistar rats were investigated.
Methods: Sixty-four male Wistar rats were divided into eight groups (n = 8). Scopolamine (SCO) was intraperitoneally injected at a dose of 1 mg/kg/day for 10 days. The treatment groups orally received DHEA (250 mg/kg/day) and/or H. erinaceus (300 mg/kg/day) for 14 days. Afterward, the Morris water maze (MWM) and novel object recognition tests were implemented. Then, animals were anesthetized and the brain tissue samples were separated. Levels of lipid peroxidation (LPO), total antioxidant capacity (TAC), catalase activity (CAT), and brain-derived neurotrophic factor (BDNF) were determined. Also, histopathological studies were evaluated in the brain tissue samples.
Results: Administration of SCO significantly decreased spatial and cognitive memory (p < 0.001). Not only did SCO injection significantly increase the levels of the LPO but also the SCO markedly reduced the levels of the TAC, CAT activity, and the BDNF in the brain tissue. On the other hand, a combination of the DHEA and H. erinaceus showed higher efficacy than the DHEA or H. erinaceus in attenuating behavioral anomalies and improving the antioxidant defense system and BDNF levels. Histological examination was well correlated with biochemical findings regarding SCO neurodegeneration and DHEA and/or H. erinaceus neuroprotection.
Conclusion: Interestingly, ADHE and/or H. erinaceus may due to their potential neurotrophic properties be used as a new and beneficial concurrent therapy in the treatment of Alzheimer's disease-like symptoms caused by SCO.
Keywords: Hericium erinaceus; Alzheimer’s Disease; Brain-derived neurotrophic factor; Dehydroepiandrosterone; Oxidative stress; Scopolamine.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.Acta Biochim Pol. 2011;58(4):513-20. Epub 2011 Dec 6. Acta Biochim Pol. 2011. PMID: 22146133
-
A Mixture of Ginkgo biloba L. Leaf and Hericium erinaceus (Bull.) Pers. Fruit Extract Attenuates Scopolamine-Induced Memory Impairments in Mice.Oxid Med Cell Longev. 2022 Jan 27;2022:9973678. doi: 10.1155/2022/9973678. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35126824 Free PMC article.
-
Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3β inhibition.Brain Res. 2025 Jul 15;1859:149650. doi: 10.1016/j.brainres.2025.149650. Epub 2025 Apr 16. Brain Res. 2025. PMID: 40250748
-
The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease.Cells. 2022 Jul 24;11(15):2284. doi: 10.3390/cells11152284. Cells. 2022. PMID: 35892581 Free PMC article. Review.
-
Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential-A Narrative Review.Nutrients. 2025 Apr 9;17(8):1307. doi: 10.3390/nu17081307. Nutrients. 2025. PMID: 40284172 Free PMC article. Review.
Cited by
-
Supporting Neurologic Health with Mushroom Nutrition.Nutrients. 2025 May 2;17(9):1568. doi: 10.3390/nu17091568. Nutrients. 2025. PMID: 40362877 Free PMC article. Review.
-
Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health.Int J Mol Sci. 2024 Nov 12;25(22):12155. doi: 10.3390/ijms252212155. Int J Mol Sci. 2024. PMID: 39596221 Free PMC article. Review.
-
Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer's Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis.J Clin Med. 2024 Aug 26;13(17):5057. doi: 10.3390/jcm13175057. J Clin Med. 2024. PMID: 39274269 Free PMC article. Review.
References
-
- Revi, M. (2020) Alzheimer’s disease therapeutic approaches. GeNeDis 2018: Genetics and Neurodegeneration.105–116.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous